Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

DPS, Schering-Plough collaborate with HMO on asthma disease management.

Executive Summary

DPS, SCHERING-PLOUGH, MID-ATLANTIC MEDICAL THREE-WAY ASTHMA MANAGEMENT agreement will be directed toward "improving outcomes and reducing cost" for 11,000 asthma patients enrolled in the Rockville, Md.-based HMO, Mid-Atlantic Medical Services. Mid-Atlantic has negotiated a contract with its pharmacy benefit manager, SmithKline Beecham's DPS, and with Schering-Plough's disease management subsidiary, Integrated Therapeutics Group, to implement the "AsthmaCare program" of guidelines and interventions for asthma sufferers.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS025947

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel